6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T13427 | (3S,4R)-Tofacitinib | Others | |
(3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM). | |||
T13426L | (3S,4S)-Tofacitinib | Others | |
(3S,4S)-Tofacitinib, a less active enantiomer of tofacitinib, is a Janus kinases inhibitor. | |||
T6321 | Tofacitinib | Tasocitinib,CP-690550 | ROCK , Apoptosis , JAK , Src |
Tofacitinib (Tasocitinib) is an oral, small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis. | |||
T2398 | Tofacitinib Citrate | CP-690550 citrate,Tasocitinib citrate,Tofacitinib (CP-690550) Citrate | Apoptosis , Influenza Virus , JAK , Antibacterial , Antifungal |
Tofacitinib Citrate (CP-690550 citrate) is a a potent, cell-permeable inhibitor of JAK1/2/3 (IC50s: 1/20/112 nM). | |||
T70168 | Tofacitinib HCl | ||
Tofacitinib HCl, also known as tasocitinib, CP-690550, is a Janus kinase (JAK) inhibitor. Tofacitinib HCl modulates the signaling pathway at the point of JAKs, preventing the phosphorylation and activation of STATs. JAK ... | |||
T13426 | (3R,4S)-Tofacitinib | Others | |
(3R,4S)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM). |